Literature DB >> 11063868

mNotch1 signaling reduces proliferation of myeloid progenitor cells by altering cell-cycle kinetics.

T Schroeder1, U Just.   

Abstract

Notch receptors are involved in the regulation of cell-fate decisions, differentiation, and proliferation in many tissues. The expression of Notch receptors on hemopoietic cells and of cognate ligands on bone marrow stromal cells suggests a possible role for Notch signaling in the regulation of hemopoiesis. We were interested to assess the involvement of Notch1 signaling on cell proliferation of myeloid progenitor cells. Proliferation, cell-cycle status, and apoptosis of myeloid progenitor 32D cell lines engineered to permit the conditional induction of the constitutively active intracellular domain of mNotch1 (mN1(IC)) by the 4-hydroxytamoxifen(OHT)-inducible system were analyzed in the presence or absence of OHT. The induction of mN1(IC) by OHT resulted in reduction of proliferation (p<0.01) and accumulation of cells in the G(1)/G(0) phase of the cell cycle (p<0.001) without substantially affecting apoptosis of 32D cells. These effects were observed under culture conditions that allow differentiation and, to a lesser degree, under conditions that normally promote self-renewal in the absence of differentiated cells. Our data suggest that mNotch1 signaling suppresses proliferation of myeloid progenitor cells by altering cell-cycle kinetics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063868     DOI: 10.1016/s0301-472x(00)00534-8

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling.

Authors:  Tom N Taghon; Elizabeth-Sharon David; Juan Carlos Zúñiga-Pflücker; Ellen V Rothenberg
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

2.  Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands.

Authors:  Pingyan Cheng; Yulia Nefedova; Cesar A Corzo; Dmitry I Gabrilovich
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

3.  The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.

Authors:  Masahiro Masuya; Naoyuki Katayama; Natsuki Hoshino; Hiroyoshi Nishikawa; Seiji Sakano; Hiroto Araki; Hidetsugu Mitani; Hirohito Suzuki; Hiroyuki Miyashita; Kyoko Kobayashi; Kazuhiro Nishii; Nobuyuki Minami; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

4.  Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.

Authors:  Lizi Wu; Tao Sun; Karla Kobayashi; Ping Gao; James D Griffin
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Authors:  Brandon K Hadland; Stacey S Huppert; Jyotshnabala Kanungo; Yingzi Xue; Rulang Jiang; Thomas Gridley; Ronald A Conlon; Alec M Cheng; Raphael Kopan; Gregory D Longmore
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

Review 6.  Myeloproliferation and hematopoietic stem cell dysfunction due to defective Notch receptor modification by O-fucose glycans.

Authors:  Lan Zhou
Journal:  Semin Immunopathol       Date:  2012-03-14       Impact factor: 9.623

7.  Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit.

Authors:  Jean-Francois Lambert; Meng Liu; Gerald A Colvin; Mark Dooner; Christina I McAuliffe; Pamela S Becker; Bernard G Forget; Sherman M Weissman; Peter J Quesenberry
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

8.  Notch1 signaling regulates the proliferation and self-renewal of human dental follicle cells by modulating the G1/S phase transition and telomerase activity.

Authors:  Xuepeng Chen; Tianhou Zhang; Jiejun Shi; Ping Xu; Zexu Gu; Andrew Sandham; Lei Yang; Qingsong Ye
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.